Immunogenicity and immunoreactivity of Tp0821 recombinant protein from Treponema pallidum

  • Authors:
    • Ning Wu
    • Ni Li
    • Liping Hu
    • Jun He
    • Junhong Li
    • Feijun Zhao
    • Yimou Wu
  • View Affiliations

  • Published online on: June 1, 2017     https://doi.org/10.3892/mmr.2017.6675
  • Pages: 851-856
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Treponema pallidum (Tp) is responsible for invading reproductive organs and the skin in early stages, and involves almost all organs/systems at advanced stages. In the present study, screening of the dominant epitope fragment of the Tp outer membrane protein, Tp0821, was performed and the prokaryotic expression vector pQE32/Tp0821 was constructed. The denaturation and dialysis of rTp0821 were achieved through ultrasound, inclusion body washing and dissolution. Experiments in purified rTp0821‑immune New Zealand rabbits indicated that the recombinant proteins were of high immunogenicity, and the irritation led a marked humoral immune response in the New Zealand rabbits. Western blot analysis showed that the purified recombinant proteins reacted with the Tp‑positive infected serum, confirming the high level of immunoreactivity. The delayed type hypersensitivity of rTp0821 recombinant proteins was positive, indicating that rTp0821 induced a specific cell immune response and was selected as a Tp vaccine candidate protein. The findings of the present study provided novel evidence, which provided information for further investigations on the pathogenic mechanism of Tp and the development of diagnostic reagents.
View Figures
View References

Related Articles

Journal Cover

July-2017
Volume 16 Issue 1

Print ISSN: 1791-2997
Online ISSN:1791-3004

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Wu N, Li N, Hu L, He J, Li J, Zhao F and Wu Y: Immunogenicity and immunoreactivity of Tp0821 recombinant protein from Treponema pallidum. Mol Med Rep 16: 851-856, 2017
APA
Wu, N., Li, N., Hu, L., He, J., Li, J., Zhao, F., & Wu, Y. (2017). Immunogenicity and immunoreactivity of Tp0821 recombinant protein from Treponema pallidum. Molecular Medicine Reports, 16, 851-856. https://doi.org/10.3892/mmr.2017.6675
MLA
Wu, N., Li, N., Hu, L., He, J., Li, J., Zhao, F., Wu, Y."Immunogenicity and immunoreactivity of Tp0821 recombinant protein from Treponema pallidum". Molecular Medicine Reports 16.1 (2017): 851-856.
Chicago
Wu, N., Li, N., Hu, L., He, J., Li, J., Zhao, F., Wu, Y."Immunogenicity and immunoreactivity of Tp0821 recombinant protein from Treponema pallidum". Molecular Medicine Reports 16, no. 1 (2017): 851-856. https://doi.org/10.3892/mmr.2017.6675